Status:

UNKNOWN

Primary Prophylaxis for Variceal Bleed in Biliary Atresia

Lead Sponsor:

Institute of Liver and Biliary Sciences, India

Conditions:

Portal Hypertension, Biliary Atresia

Eligibility:

All Genders

6-5 years

Phase:

NA

Brief Summary

Biliary atresia is the commonest etiology of neonatal cholestasis and is the most common indication for pediatric liver transplantation world-wide. Kasai-portoenterostomy (KPE) is the operative proced...

Detailed Description

(a) Aim and Objectives: Aim: To study the effect of beta-blockers for primary prophylaxis of variceal bleed in infants and children with biliary atresia. Primary objective: Bleeding free survival ov...

Eligibility Criteria

Inclusion

  • Infants and children with biliary atresia from 6 months to 5 years of age fulfilling either of the following conditions:
  • i. With unsuccessful Kasai portoenterostomy procedure with a bilirubin \>2 mg/dL, or ii. Who did not underwent Kasai portoenterostomy, or iii. With successful Kasai portoenterostomy procedure with a bilirubin \<2 mg/dL, but with features of portal hypertension i.e. clinical splenomegaly and/or thrombocytopenia (platelets \< 1,00,000/mm3).

Exclusion

  • i. History suggestive of hyper-reactive airway disease. ii. Congestive heart failure iii. Any degree of heart block (I,, II, III) iv. Infants and children already on beta-blockers in last 4 weeks. v. Portal vein atresia or thrombosis. vi. History of variceal bleed. vii. Infants and children on prophylactic or therapeutic endotherapy (band ligation or sclerotherapy).
  • viii. Potential liver transplant within 1 month.

Key Trial Info

Start Date :

August 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 15 2022

Estimated Enrollment :

92 Patients enrolled

Trial Details

Trial ID

NCT04494763

Start Date

August 15 2020

End Date

June 15 2022

Last Update

March 18 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Liver and Biliary Sciences

New Delhi, National Capital Territory of Delhi, India, 110070